UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000033374 |
|---|---|
| Receipt number | R000038048 |
| Scientific Title | Efficacy of S-1 after Pemetrexed in patient with non-squamous non-small cell carcinoma: a retrospective multi-institutional analysis |
| Date of disclosure of the study information | 2018/07/12 |
| Last modified on | 2021/01/12 15:21:35 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Efficacy of S-1 after Pemetrexed in patient with
non-squamous non-small cell carcinoma:
a retrospective multi-institutional analysis
Acronym
Efficacy of S-1 after Pemetrexed in patient with
non-squamous non-small cell carcinoma:
a retrospective multi-institutional analysis
Scientific Title
Efficacy of S-1 after Pemetrexed in patient with
non-squamous non-small cell carcinoma:
a retrospective multi-institutional analysis
Scientific Title:Acronym
Efficacy of S-1 after Pemetrexed in patient with
non-squamous non-small cell carcinoma:
a retrospective multi-institutional analysis
Region
| Japan |
Condition
Condition
Non small-cell lung cancer patients receiving both PEM and S-1
Classification by specialty
| Pneumology |
Classification by malignancy
Malignancy
Genomic information
NO
Objectives
Narrative objectives1
To verify the effect of S-1 after PEM
Basic objectives2
Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Response Rate of S-1
Key secondary outcomes
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 18 | years-old | <= |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
Non small-cell lung cancer patients recieving PEM and S-1 between April 1, 2012 to March 31, 2017
Key exclusion criteria
Nothing
Target sample size
80
Research contact person
Name of lead principal investigator
| 1st name | Shinnosuke |
| Middle name | |
| Last name | Takemoto |
Organization
National Hospital Organization, Nagasaki Medical Center
Division name
Respiratoey of Medicine
Zip code
8573121
Address
Kubara 2-1001-1,Omura, Nagasaki, japan
TEL
0957-52-3121
shinnosuke-takemoto@umin.ac.jp
Public contact
Name of contact person
| 1st name | Shinnosuke |
| Middle name | |
| Last name | Takemoto |
Organization
National Hospital Organization, Nagasaki Medical Center
Division name
Respiratoey of Medicine
Zip code
8573121
Address
Kubara 2-1001-1,Omura, Nagasaki, japan
TEL
0957-52-3121
Homepage URL
shinnosuke-takemoto@umin.ac.jp
Sponsor or person
Institute
National Hospital Organization, Nagasaki Medical Center
Institute
Department
Personal name
Funding Source
Organization
No research fund
Organization
Division
Category of Funding Organization
Other
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Nagasaki Medical Center
Address
Kubara 1001-2, Omura City, Nagasak
Tel
09578523121
shinnosuke-takemoto@umin.ac.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2018 | Year | 07 | Month | 12 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Completed
Date of protocol fixation
| 2018 | Year | 06 | Month | 10 | Day |
Date of IRB
| 2018 | Year | 06 | Month | 08 | Day |
Anticipated trial start date
| 2018 | Year | 06 | Month | 08 | Day |
Last follow-up date
| 2020 | Year | 03 | Month | 31 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Nothing
Management information
Registered date
| 2018 | Year | 07 | Month | 12 | Day |
Last modified on
| 2021 | Year | 01 | Month | 12 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000038048
